Will hoth surge today

**Hoth Therapeutics (HOTH) is likely to surge today**, based on the following analysis: 1. **Promising Preclinical Results**: The company has recently announced encouraging preclinical results for its Alzheimer's drug, HT-ALZ, which has led to a significant increase in the stock price. This positive news is likely to continue driving investor interest and optimism. 2. **Technical Indicators**: The stock's 5-day moving average is $1.11, and the 10-day moving average is $1.07, suggesting a short-term upward trend. Additionally, the Relative Strength Index (RSI) is 59.85, which is close to the overbought territory but still indicates a bullish sentiment. 3. **Market Sentiment**: The stock has a buy signal according to the Short-term Trend Forecast, and the recent insider purchase by CEO Knie Robb indicates confidence in the company's future, which is a positive sign for investors. 4. **Price Target**: The stock currently has a 1-year price target of $4.50, which is significantly higher than the current price, suggesting potential for growth. This price target reflects analysts' expectations of future performance, which could attract more investors. 5. **Recent Performance**: The stock has shown a significant rise over the past week and month, indicating a strong bullish trend. This recent performance suggests that the positive momentum could continue. In conclusion, the combination of positive preclinical news, technical indicators pointing to an upward trend, and positive market sentiment, all support the likelihood of HOTH surging today.